|
WO2021076851A1
|
|
Biologically synthesized hydroxyapatite for bone regeneration and tissue engineering
|
|
WO2021072374A1
|
|
Use of simultaneous marker detection for assessing difuse glioma and responsiveness to treatment
|
|
WO2021067943A1
|
|
Piezo1 agonists for the promotion of bone formation
|
|
WO2021034693A1
|
|
Powered orthotic device for hand extension and methods of use thereof
|
|
WO2020150256A1
|
|
Indole molecules and use thereof in the inhibition of dna polymerases
|
|
WO2020106880A1
|
|
Cells for the production of viruses and methods of using the same
|
|
WO2019227022A1
|
|
Myxoma virus compositions and methods of use
|
|
WO2019183131A1
|
|
Periostin antibodies and methods of using the same
|
|
US2019249136A1
|
|
Method of Coating Surfaces with Nanoparticles for Biological Analysis of Cells
|
|
CN112105360A
|
|
BCL-2 protein degrading agents for cancer treatment
|
|
BR112020007447A2
|
|
USE OF AMINO ACIDS SUPPLEMENTATION IN THE SYNTHESIS OF ENHANCED MUSCLE PROTEIN
|
|
US2019054097A1
|
|
Compositions targeting senescent cells and the uses thereof
|
|
WO2019060685A1
|
|
System and method of phenotype and polynucleotide sequencing analyses for biological particles via deterministic barcoding
|
|
US2019049430A1
|
|
OMA1 activity assay
|
|
AU2018312110A1
|
|
Linear lipopeptide paenipeptins and methods of using the same
|
|
WO2018222871A1
|
|
Methods for creating and delivering neuromodulatory stimulation
|
|
WO2019221755A1
|
|
Piperlongumine analogues and uses thereof
|
|
US2018244641A1
|
|
Tocopherol derivatives and methods of use
|
|
US2020101080A1
|
|
Inhibitors of dna pk and uses thereof
|
|
WO2018160880A1
|
|
Compositions and methods for detecting sessile serrated adenomas/polyps
|
